Gary Phillips

Gary Phillips is the current president of the San Diego Tech Coast Angels, an affiliate of the largest angel investor group in the United States. Members of the Tech Coast Angels provide funding and guidance to more early-stage, high-growth companies in Southern California than any other investment group.

Recent posts

Help Save Our Innovation Economy from the SEC’s Rewrite of Reg D
Over the past 30 years, the United States has developed an infrastructure to nurture, grow, and fund early stage companies that is the envy of the world. There are more than... Read more »
Exit Early and Often: A New Age of Limited Options for Entrepreneurs
I rarely meet an entrepreneur (or one of their investors) who doesn’t believe their venture will be a runaway hit. In three to five years, I hear over and over, we’ll... Read more »
How the TCA is Making 2013 The Year of the Angel Investor
A number of pundits have been claiming that angel investment is waning, and that such funding opportunities will remain few and far between for deserving startups seeking to take their innovations... Read more »

Page 1 of 1

Underwriters and Partners

Xconomy Insight

Sponsored · Whitepaper
Time Savings That Speed up Science
Monitor spending and save meaningful dollars with life sciences-specific rewards
Brex

Sponsored · Whitepaper
IBM Watson Health Data in Action – Epidemiology Studies
With data from IBM Watson Health, epidemiologists can describe treatment patterns, persistence & adherence to therapy
IBM Watson

Xconomy Insight · Special Report
How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook
Insights, wisdom, and inspiration on what it takes

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy National

UK Reveals Plans For ‘Dynamic’ Post-Brexit Regulatory System

Bicycle Therapeutics Lands $30M From Genentech in New Cancer R&D Pact

BioIntelliSense Debuts "Sticker” Sensor to Capture Patient Data Remotely

Esperion's Combo Pill for Lowering Cholesterol Levels Wins FDA Nod

Eli Lilly Gets Skin in the Eczema Game With $1.1B Deal for Dermira

Agile Therapeutics Wins FDA Nod for Twirla Contraceptive Patch

Dova Pharmaceuticals Agrees to Sobi Acquisition, Shares Jump 38%

Takeda Bases PvP Biologics Buyout on Promising Early Celiac Drug Data

With Foamix Merger Weeks Away, Menlo Itching Drug Fails a Phase 2 Test

SeaGen Adds Five Prime Therapeutics Antibodies in Licensing Deal

Reata’s Kidney Drug Hits Goals of Key Study, Paves Way for FDA Filing

AI Can Unlock Health Data's Potential, But Access Is Still Difficult

Coughlin Takes Over as Chief Medical Officer at Rubius

Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More

Xcelerating Life Sciences San Diego

Xcelerating Life Sciences Boston

Xcelerating Life Sciences Philadelphia

Gary Phillips

Recent posts

Help Save Our Innovation Economy from the SEC’s Rewrite of Reg D

Exit Early and Often: A New Age of Limited Options for Entrepreneurs

How the TCA is Making 2013 The Year of the Angel Investor

Underwriters and Partners

Time Savings That Speed up Science

IBM Watson Health Data in Action – Epidemiology Studies

How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook

Xconomy on Demand

We offer a number of ways to subscribe for free!